Article 01 Jul 2025 Enablement, Anticipation, And Claim Strategy: Rethinking Biotech Patent Drafting Post-Agilent United States IP
Article 26 Mar 2024 Routine Optimization Does Not Necessarily Require A Disclosure Of Ranges Under The Results-Effective Variable Doctrine – Pfizer V. Sanofi, No. 19-1871 (Fed Cir 2024) United States IP
